Personal information

Verified email domains

Ras, NF1, cancer biology, drug discovery, bioinformatics, cheminformatics
United States

Activities

Employment (5)

Sage Bionetworks: Seattle, US

2024-10-01 to present | Associate Director (Rare Disease)
Employment
Source: Self-asserted source
Robert Allaway

Sage Bionetworks: Seattle, Washington, US

2022-02-01 to present | Principal Scientist
Employment
Source: Self-asserted source
Robert Allaway

Sage Bionetworks: Seattle, Washington, US

2020-02-01 to 2022-02-01 | Senior Scientist (Computational Oncology)
Employment
Source: Self-asserted source
Robert Allaway

Sage Bionetworks: Seattle, Washington, US

2018-06-01 to 2020-02-01 | Research Scientist (Computational Oncology)
Employment
Source: Self-asserted source
Robert Allaway

Sage Bionetworks: Seattle, Washington, US

2016-10-31 to 2018-06-01 | Postdoctoral Fellow (Computational Oncology)
Employment
Source: Self-asserted source
Robert Allaway

Education and qualifications (2)

Dartmouth College Geisel School of Medicine: Hanover, NH, US

2011 to 2016-10-15 | PhD Experimental and Molecular Medicine (Department of Molecular and Systems Biology)
Education
Source: Self-asserted source
Robert Allaway

Dickinson College: Carlisle, PA, US

2007 to 2011 | BS Biology, BS Chemistry
Education
Source: Self-asserted source
Robert Allaway

Professional activities (11)

REiNS (Response Evaluation in Neurofibromatosis and Schwannomatosis): n/a, US

2025-01 to present (AI Working Group)
Service
Source: Self-asserted source
Robert Allaway

International Rare Diseases Research Consortium (IRDiRC): Ivry-sur-Seine, FR

2024-05-01 to present | Member (Interdisciplinary Scientific Committee)
Service
Source: Self-asserted source
Robert Allaway

International Society for Biocuration: Geneva, CH

2022 to present | Member
Membership
Source: Self-asserted source
Robert Allaway

Open Bioinformatics Foundation: N/A, US

2021 to present | Member
Membership
Source: Self-asserted source
Robert Allaway

Calyx Institute: New York, NY, US

2021 to present | Sustainer
Membership
Source: Self-asserted source
Robert Allaway

Data Visualization Society: Washington, DC, US

2019 to present | Member
Membership
Source: Self-asserted source
Robert Allaway

American Association for Cancer Research: Philadelphia, PA, US

2018 to present | Active Member
Membership
Source: Self-asserted source
Robert Allaway

International Rare Diseases Research Consortium (IRDiRC): Ivry-sur-Seine, FR

2023-01 to 2024-04-30 | Member (Functional Analysis Task Force)
Service
Source: Self-asserted source
Robert Allaway

Puget Sound Mycological Society: Seattle, WA, US

2021 to 2023 | Member
Membership
Source: Self-asserted source
Robert Allaway

International Society for Computational Biology: La Jolla, CA, US

2019 to 2021 | Member
Membership
Source: Self-asserted source
Robert Allaway

American Chemical Society: Washington, DC, US

2013 to 2019 | Member
Membership
Source: Self-asserted source
Robert Allaway

Funding (20)

Accelerating NF Data Sharing with AI and Data Roadmap Tools

2025-02 to 2030-02 | Contract
Gilbert Family Foundation (MI, MI, US)
Source: Self-asserted source
Robert Allaway

LINCing data at scale in the age of AI and digital dignity

2024-09 to present | Grant
ARPA-H (Washington, DC, US)
Source: Self-asserted source
Robert Allaway

Neurofibromatosis Research Tools Database - Enhancement & Dissemination

2022-05 to 2023-10 | Contract
Gilbert Family Foundation (MI, MI, US)
Source: Self-asserted source
Robert Allaway

Maintenance of the NF Data Portal and NTAP Grantee Data Sharing Support

2022-01 to 2024-12 | Contract
Neurofibromatosis Therapeutic Acceleration Program (Baltimore, Md., US)
Source: Self-asserted source
Robert Allaway

NTAP Genomic Data Processing

2022-01 to 2024-12 | Contract
Neurofibromatosis Therapeutic Acceleration Program (Baltimore, Md., US)
Source: Self-asserted source
Robert Allaway

Uncovering New Mechanisms of NF1 Disease Biology and Identifying New Therapeutic Opportunities

2022-01 to 2024-12 | Contract
Neurofibromatosis Therapeutic Acceleration Program (Baltimore, Md., US)
Source: Self-asserted source
Robert Allaway

Development of a Prototype Neurofibromatosis Research Tools Database and Companion Web Explorer Application

2022 to 2023 | Contract
Gilbert Family Foundation (MI, MI, US)
Source: Self-asserted source
Robert Allaway

Training and Support of a Children’s Tumor Foundation Young Investigator

2021-09-01 to 2025-03-31 | Grant
Children's Tumor Foundation (New York, US)
GRANT_NUMBER:

2021-04-007

Source: Self-asserted source
Robert Allaway via DimensionsWizard

Training and Support of a Children’s Tumor Foundation Young Investigator

2021-09-01 to 2025-02-28 | Grant
Children's Tumor Foundation (New York, US)
GRANT_NUMBER:

CTF-2021-04-007

Source: check_circle
Children's Tumor Foundation

Maintenance of the NF Data Portal and CTF Grantee Data Sharing Support

2021-07-01 to 2025-06-30 | Grant
Children's Tumor Foundation (New York, US)
GRANT_NUMBER:

2021-04-006

Source: Self-asserted source
Robert Allaway via DimensionsWizard

Maintenance of the NF Data Portal and CTF Grantee Data Sharing Support

2021-07-01 to 2024-06-30 | Grant
Children's Tumor Foundation (New York, US)
GRANT_NUMBER:

CTF-2021-04-006

Source: check_circle
Children's Tumor Foundation

Exploiting Aneuploidy in NF1-MPNST: Prognostication and Understanding Pathogenesis

2021 to 2024 | Contract
Congressionally Directed Medical Research Programs (Frederick, Maryland, US)
Source: Self-asserted source
Robert Allaway

Preclinical Evaluation of PAK and BRD4 Inhibitors for NF2

2021 to 2024 | Grant
Congressionally Directed Medical Research Programs (Frederick, Maryland, US)
Source: Self-asserted source
Robert Allaway

Regulating Neurofibromin Through Degradation, Dimerization, and Binding to SPRED1

2021 to 2023 | Grant
Congressionally Directed Medical Research Programs (Md., Md., US)
Source: Self-asserted source
Robert Allaway

Development and Management of Gilbert Family Foundation Organization Page and Study Pages on the NF Data Portal

2020 to 2023 | Contract
Gilbert Family Foundation (MI, MI, US)
Source: Self-asserted source
Robert Allaway

Development and Management of Gilbert Family Foundation Shared Workspace and Program Workspaces

2020 to 2023 | Contract
Gilbert Family Foundation (MI, MI, US)
Source: Self-asserted source
Robert Allaway

Creation of a NF Data Portal and knowledge database for the scientific community (2018-2021)

2018-07 to 2022-04 | Contract
Children's Tumor Foundation (NY, NY, US)
GRANT_NUMBER: CTF-2018-04-002
Source: Self-asserted source
Robert Allaway

NTAP Data and Knowledge Portal for NF1

2018 to 2021 | Contract
Neurofibromatosis Therapeutic Acceleration Program (Baltimore, MD, US)
Source: Self-asserted source
Robert Allaway

In Support of CTF Synodos Project - Robert Allaway Salary & Benefits

2016-10-31 to 2018-06-30 | Grant
Children's Tumor Foundation (New York, US)
GRANT_NUMBER:

CTF-2016-04-003

Source: Self-asserted source
Robert Allaway via DimensionsWizard

Characterizing novel therapeutics that exhibit synthetic lethality with NF1-associated tumors

2014-07-31 to 2016-07-30 | Grant
Children's Tumor Foundation (New York, US)
GRANT_NUMBER:

CTF-2014-01-012

Source: Self-asserted source
Robert Allaway via DimensionsWizard

Peer review (18 reviews for 7 publications/grants)

Review activity for Bioinformatics (1)
Review activity for BMC cancer (2)
Review activity for Journal of Cellular and Molecular Medicine. (3)
Review activity for Journal of cheminformatics. (6)
Review activity for Orphanet journal of rare diseases. (1)
Review activity for Pharmaceutical medicine. (1)
Review activity for PLoS computational biology. (4)